Try our Advanced Search for more refined results
Private Equity
-
February 11, 2026
Anesthesia Group Looks To End FTC Rollup Suit
U.S. Anesthesia Partners has urged a Texas federal court to end the Federal Trade Commission's case accusing the group of buying competing practices through a so-called rollup strategy, asserting that enforcers have no evidence of any harm to competition.
-
February 11, 2026
Steward Health Creditor Trust Seeks $56M From Insurers
The creditor litigation trust for the Texas Chapter 11 case of hospital operator Steward Health Care has filed adversary suits against six groups of health insurance companies, seeking payment of covered medical bills totaling more than $56 million.
-
February 11, 2026
Ancora Opposes Netflix-WBD Merger, Backs Paramount Bid
Ancora Holdings Group said Wednesday it opposes Warner Bros. Discovery's planned merger with Netflix, faulting the deal's financial structure and describing its path to regulatory approval as a "Hail Mary," while supporting a competing bid from Paramount Skydance Corp.
-
February 11, 2026
Paul Hastings Adds Ex-Norton Rose Investment Funds Pro
Paul Hastings LLP has added an investment funds specialist who previously worked with Norton Rose Fulbright as a partner in its Chicago office, the firm announced Wednesday.
-
February 11, 2026
Financial Advisory Co. Province Acquires StoneTurn
Restructuring and financial advisory firm Province announced on Wednesday the purchase of compliance advisory firm StoneTurn, resulting in a combined company of 300 professionals operating across 19 offices on five continents.
-
February 11, 2026
Sustainability Investor Raises $2.4B In Latest Fund Close
Vision Ridge Partners, a Boulder, Colorado-based investor in sustainability-focused assets, on Wednesday said it has raised $2.4 billion in its largest-ever fundraising, represented by Kirkland & Ellis LLP.
-
February 11, 2026
Weil, Latham Lead Solar Project Builder's $513M IPO
Power infrastructure provider Solv Energy Inc. hit the public markets Wednesday after raising nearly $513 million in its initial public offering.
-
February 11, 2026
Blue Owl Wraps $3B Strategic Equity, Secondaries Fund
Private equity shop Blue Owl Capital Inc. on Wednesday revealed that it closed its inaugural strategic equity and secondaries fund with over $3 billion of capital commitments.
-
February 11, 2026
Paul Weiss, Dechert Steer QXO's $2.25B Kodiak Buy
Building products distributor QXO Inc. said Wednesday it has agreed to acquire Kodiak Building Partners from Court Square Capital Partners for approximately $2.25 billion, with Paul Weiss Rifkind Wharton & Garrison LLP advising QXO and Dechert LLP representing Kodiak.
-
February 10, 2026
Paul Hastings Lands 8 More Attys For New Charlotte Office
A second group of fund finance lawyers has joined Paul Hastings LLP's new Charlotte, North Carolina, office from Cadwalader Wickersham & Taft LLP, Haynes Boone and Mayer Brown LLP.
-
February 10, 2026
Presidio Seeks $1B Debt To Fund Deals After SPAC Merger
Oil and gas operator Presidio Investment Holdings on Tuesday revealed that it is working with banking giant Goldman Sachs on a debt facility worth up to $1 billion to be administered once it completes its merger with special purpose acquisition company EQV Ventures Acquisition Corp. and becomes a public company.
-
February 10, 2026
Freshfields, Kirkland Steer $6.2B Clear Channel Outdoor Deal
Advertising company Clear Channel Outdoor Holdings Inc. has agreed to be acquired by Mubadala Capital in partnership with TWG Global in an all-cash deal valuing the company at $6.2 billion.
-
February 10, 2026
European Wax Center To Go Private In $330M Cash Deal
Waxing services giant European Wax Center Inc. on Tuesday announced plans to go private after being acquired by investor General Atlantic in an all-cash deal valued at roughly $330 million.
-
February 10, 2026
AI Docs Sent By Exec To Attys Not Privileged, Judge Says
A Manhattan federal judge said Tuesday that a Texas financial services executive accused of a $150 million fraud cannot claim privilege over documents that he prepared using an artificial intelligence service and sent to his attorneys — but suggested the materials could be problematic if used at trial.
-
February 10, 2026
Whooping Cough-Focused Biotech Wraps $115M Fundraise
Florida-based biotechnology company ILiAD Biotechnologies Inc. on Tuesday revealed that it wrapped its latest financing round after securing $115 million from investors, which will be used to advance development on a potential whooping cough vaccine.
-
February 09, 2026
Conn. AG Launches Blight Probe Of JRK-Owned Apartments
Connecticut officials Monday launched a state unfair trade practices probe into the California-based owners of a 500-unit apartment complex, with the state attorney general slamming private equity-owned real estate groups while saying years of complaints culminated with recent burst pipes and evacuation orders in sub-zero temperatures.
-
February 09, 2026
Catching Up With Delaware's Chancery Court
Delaware's chancellor has rejected a bid for dismissal of a derivative suit accusing Coinbase Global Inc. insiders of massively unloading shares ahead of a steep stock drop, stressing a special litigation committee's failure to meet independence standards.
-
February 09, 2026
Fried Frank Hires Pillsbury M&A, PE Head
Fried Frank Harris Shriver & Jacobson LLP announced Monday that it has hired the former head of Pillsbury Winthrop Shaw Pittman LLP's mergers and acquisitions and private equity practices, touting his transactional experience across a wide range of industries.
-
February 09, 2026
Safanad Sells UK Care Home Biz To REIT For $1.6B
Principal-led investment company Safanad announced Monday that it sold U.K. care-home provider HC-One to a healthcare real estate investment trust for over $1.6 billion.
-
February 09, 2026
Slaughter And May Leads NatWest £2.7B Wealth Manager Buy
NatWest said Monday that it has agreed to acquire British wealth manager Evelyn Partners from Permira, a global investment company, and private equity firm Warburg Pincus for £2.7 billion ($3.7 billion) to boost its private banking and wealth management business.
-
February 09, 2026
Kirkland, McDermott-Led GBL To Buy €500M Medical Biz Stake
Groupe Bruxelles Lambert said Monday it has agreed to acquire a 45% stake in Rayner, a U.K.-based medical eye treatment manufacturer, for €500 million ($596 million) from private equity company CVC, as the Belgian investment holding company moves to expand its private healthcare portfolio.
-
February 09, 2026
Schroders, Apollo Team Up On Wealth, Retirement Products
British investment manager Schroders PLC and U.S. private equity firm Apollo Global Management Inc. said Monday that they will team up to provide investment and retirement products to wealthy clients on both sides of the Atlantic.
-
February 09, 2026
White & Case-Led CVC To Buy Animal Health Biz For €2.2B
CVC said Monday that it has agreed to acquire the animal nutrition and health business from DSM-Firmenich, a Swiss-Dutch chemical company, for an enterprise value of €2.2 billion ($2.6 billion), as the private equity firm pushes to diversify its focus.
-
February 09, 2026
Weil Helps Advent, FedEx Buy Poland's InPost For €7.8B
A consortium that includes U.S. private equity firm Advent International LP and FedEx Corp. said Monday that it has agreed to buy InPost for €7.8 billion ($9.2 billion) to back the growth in Europe of the Polish parcel locker company.
-
February 06, 2026
Kirkland Leads Jennifer Garner's Baby Food Co.'s $198M IPO
Once Upon a Farm, an organic baby food brand co-founded by actor Jennifer Garner, began trading Friday after it raised nearly $198 million by offering 11 million shares, in an offering guided by Kirkland & Ellis LLP and Weil Gotshal & Manges LLP.
Expert Analysis
-
Series
Adapting To Private Practice: From ATF Director To BigLaw
As a two-time boomerang partner, returning to BigLaw after stints as a U.S. attorney and the director of the Bureau of Alcohol, Tobacco, Firearms and Explosives, people ask me how I know when to move on, but there’s no single answer — just clearly set your priorities, says Steven Dettelbach at BakerHostetler.
-
What To Know As SEC Looks To Expand Private Fund Access
As the U.S. Securities and Exchange Commission considers expanding retail access to private markets, understanding how these funds operate — and the role of financial intermediaries in guiding investors — is increasingly important, say attorneys at K&L Gates.
-
Balancing The Promises And Perils Of Tokenizing Securities
Tokenizing listed securities offers the promise of greater efficiency, accessibility and innovation, but a recent U.S. Securities and Exchange Commission statement makes clear that the federal securities laws continue to apply to tokenized securities, so financial institutions and technology developers must work together to create clear rules, say attorneys at Orrick.
-
SEC, FINRA Obligations In Changing AI Regulatory Landscape
Despite the U.S. Securities and Exchange Commission's recent withdrawal of its proposed artificial intelligence conflict rules, financial regulators remain focused on firms developing the correct AI compliance framework, as well as continuously testing and supervising them to ensure they're fit for purpose, say attorneys at Cahill Gordon.
-
Series
Playing Baseball Makes Me A Better Lawyer
Playing baseball in college, and now Wiffle ball in a local league, has taught me that teamwork, mental endurance and emotional intelligence are not only important to success in the sport, but also to success as a trial attorney, says Kevan Dorsey at Swift Currie.
-
A Deep Dive Into 14 Nixed Gensler-Era SEC Rule Proposals
The U.S. Securities and Exchange Commission last month formally withdrew 14 notices of proposed rulemaking, including several significant and widely criticized proposals that had been issued under former Chair Gary Gensler's leadership, signaling a clear and definitive shift away from the previous administration, say attorneys at Dechert.
-
Series
Law School's Missed Lessons: Skillful Persuasion
In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.
-
A Look At Trump 2.0 Antitrust Enforcement So Far
The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforcement tempered by traditional structural remedies for mergers, but other unprecedented actions, like the firing of Federal Trade Commission Democrats, will likely stoke heated discussion ahead, says Richard Dagen at Axinn.
-
How Real Estate Funds Can Leverage Del. Statutory Trusts
Over the last two years, traditional real estate fund sponsors have begun to more frequently adopt Delaware Statutory Trust programs, which can help diversify capital-raising strategies and access to new sources of capital, among other benefits, say attorneys at Polsinelli.
-
Litigation Inspiration: How To Respond After A Loss
Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.
-
Tips For Cos. From California Climate Reporting FAQ
New guidance from the California Air Resources Board on how businesses must implement the state's sweeping climate reporting requirements should help companies assess their exposure, understand their disclosure obligations and begin documenting good-faith compliance efforts, says Thierry Montoya at Frost Brown.
-
Weighing PE Transaction Risks As EU AI Act Rolls Out
As the European Union Artificial Intelligence Act becomes effective in stages, legal practitioners involved in private equity deals should consider the transactional risks resulting from this measure, including penalties, extraterritorial reach and target-firm applicability, say lawyers at Covington.
-
Why SEC Abandoned Microcap Convertible Debt Crackdown
The U.S. Securities and Exchange Commission has recently dismissed several cases targeting microcap convertible debt lenders, a significant disavowal of what was a controversial enforcement initiative under the Biden administration and a message that the new administration will focus on clear fraud, say attorneys at O'Melveny.
-
The Metamorphosis Of The Major Questions Doctrine
The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.
-
Biotech Collaborations Can Ease Uncertainty Amid FDA Shift
As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.